{"chebi_id":"133817","chebi_name":"doxorubicinol","chebi_synonyms":["13-dihydrodoxorubicin","(1S,3S)-3-[(1S)-1,2-dihydroxyethyl]-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-\u03b1-L-lyxo-hexopyranoside","Antibiotic 27706RP","DOXOL","adriamycinol"],"diffprof_id_observed":["MTBLS2384_0002_00000005","MTBLS3750_0002_00000006"],"diffprof_id_var_observed":["MTBLS2384_0002_00000005"],"inchikey":"NKZRZOVSJNSBFR-FEMMEMONSA-N","inn_name":"","iupac_name":"(1<i>S</i>,3<i>S</i>)-3-[(1<i>S</i>)-1,2-dihydroxyethyl]-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-\u03b1-<small>L</small>-<i>lyxo</i>-hexopyranoside","num_study_observed":2,"reactome_ids":["R-HSA-1430728","R-HSA-211859","R-HSA-211945"],"reactome_names":["Metabolism","Biological oxidations","Phase I - Functionalization of compounds"],"study_id_observed":["MTBLS2384","MTBLS3750"],"study_id_var_observed":["MTBLS2384"],"synonym_name":"13-dihydrodoxorubicin"}